Home > News > Nanogen to Present at UBS Global Life Sciences Conference
September 18th, 2003
Nanogen to Present at UBS Global Life Sciences Conference
Nanogen, Inc. a leading provider of molecular diagnostics, today announced Howard Birndorf, Nanogen's Chairman and CEO, will present an overview of the Company on Monday, September 22 at 10:00 a.m. EST during the UBS Global Life Sciences Conference. The conference will take place September 22-25 at The Plaza Hotel in New York City and will feature presentations by the life science industry's leading public companies, as well as a select group of top privately held biotechnology companies.
Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014
QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014
Advancing thin film research with nanostructured AZO: Innovnano’s unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014
Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014